PIMECROLIMUS (1% CREAM) IN TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN: EFFICIENCY AND SAFETY
The main objective for treatment of atopic dermatitis is to achieve the full control. Despite the fact that control fundamentals for treatment of atopic dermatitis among children are implemented in the clinical practice, it's practically impossible as of now to deem the control of a disease as...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2007-04-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/648 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849404751189377024 |
|---|---|
| author | L.M. Ogorodova I.A. Deev E.S. Kulikov E.V. Deeva |
| author_facet | L.M. Ogorodova I.A. Deev E.S. Kulikov E.V. Deeva |
| author_sort | L.M. Ogorodova |
| collection | DOAJ |
| description | The main objective for treatment of atopic dermatitis is to achieve the full control. Despite the fact that control fundamentals for treatment of atopic dermatitis among children are implemented in the clinical practice, it's practically impossible as of now to deem the control of a disease as satisfactory. Such a situation is due to two main reasons: for one thing, in 37,4% of cases the severity of a disease is incorrectly assessed, which entails the prescription of a therapy that is inadequate to the degree of clinical presentations; secondly, among both doctors and patients there is still a glucocorticoidophobia, which leads to application of medications with low efficiency profile in therapy and then due to no control of atopic deramatitis it justifies the necessity to prescribe peroral glucoacorticoids. in this respect, application of calcineurin inhibitors (pimecrolimus 1% cream — elidel) as a basic therapy may be a real solution to this problem for the children, suffering from mild and moderate atopic dermatitis, to achieve the longaterm control over the disease symptoms.Key words: atopic dermatitis, children, pimecrolimus, treatment, efficiency, safety. |
| format | Article |
| id | doaj-art-5ea8216e8ab941c1934e7e57d5afde68 |
| institution | Kabale University |
| issn | 1727-5776 2500-3089 |
| language | Russian |
| publishDate | 2007-04-01 |
| publisher | Union of pediatricians of Russia |
| record_format | Article |
| series | Педиатрическая фармакология |
| spelling | doaj-art-5ea8216e8ab941c1934e7e57d5afde682025-08-20T03:36:53ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892007-04-01427175644PIMECROLIMUS (1% CREAM) IN TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN: EFFICIENCY AND SAFETYL.M. Ogorodova0I.A. Deev1E.S. Kulikov2E.V. Deeva3Siberian State Medical University, TomskSiberian State Medical University, TomskSiberian State Medical University, TomskSiberian State Medical University, TomskThe main objective for treatment of atopic dermatitis is to achieve the full control. Despite the fact that control fundamentals for treatment of atopic dermatitis among children are implemented in the clinical practice, it's practically impossible as of now to deem the control of a disease as satisfactory. Such a situation is due to two main reasons: for one thing, in 37,4% of cases the severity of a disease is incorrectly assessed, which entails the prescription of a therapy that is inadequate to the degree of clinical presentations; secondly, among both doctors and patients there is still a glucocorticoidophobia, which leads to application of medications with low efficiency profile in therapy and then due to no control of atopic deramatitis it justifies the necessity to prescribe peroral glucoacorticoids. in this respect, application of calcineurin inhibitors (pimecrolimus 1% cream — elidel) as a basic therapy may be a real solution to this problem for the children, suffering from mild and moderate atopic dermatitis, to achieve the longaterm control over the disease symptoms.Key words: atopic dermatitis, children, pimecrolimus, treatment, efficiency, safety.https://www.pedpharma.ru/jour/article/view/648 |
| spellingShingle | L.M. Ogorodova I.A. Deev E.S. Kulikov E.V. Deeva PIMECROLIMUS (1% CREAM) IN TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN: EFFICIENCY AND SAFETY Педиатрическая фармакология |
| title | PIMECROLIMUS (1% CREAM) IN TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN: EFFICIENCY AND SAFETY |
| title_full | PIMECROLIMUS (1% CREAM) IN TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN: EFFICIENCY AND SAFETY |
| title_fullStr | PIMECROLIMUS (1% CREAM) IN TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN: EFFICIENCY AND SAFETY |
| title_full_unstemmed | PIMECROLIMUS (1% CREAM) IN TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN: EFFICIENCY AND SAFETY |
| title_short | PIMECROLIMUS (1% CREAM) IN TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN: EFFICIENCY AND SAFETY |
| title_sort | pimecrolimus 1 cream in treatment of atopic dermatitis among children efficiency and safety |
| url | https://www.pedpharma.ru/jour/article/view/648 |
| work_keys_str_mv | AT lmogorodova pimecrolimus1creamintreatmentofatopicdermatitisamongchildrenefficiencyandsafety AT iadeev pimecrolimus1creamintreatmentofatopicdermatitisamongchildrenefficiencyandsafety AT eskulikov pimecrolimus1creamintreatmentofatopicdermatitisamongchildrenefficiencyandsafety AT evdeeva pimecrolimus1creamintreatmentofatopicdermatitisamongchildrenefficiencyandsafety |